TY  - JOUR
T1  - NEw therapies for gi cancers fall short
AU  - Hampton T
Y1  - 2009/07/22
N1  - 10.1001/jama.2009.1021
JO  - JAMA
SP  - 373
EP  - 374
VL  - 302
IS  - 4
N2  - 
Results from several large clinical trials on cancers of the colon, rectum, and anus have failed to fulfill hopes for better treatments. Findings presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), held May 29 through June 2 in Orlando, indicate that in most cases, the current standards of care should remain the treatments of choice. However, one potentially practice-changing trial suggested that many patients with advanced colorectal cancer can forgo standard surgery and receive chemotherapy as first-line care.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.1021
UR  - http://dx.doi.org/10.1001/jama.2009.1021
ER  -